Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Aberdeen Group plc Sells 664,801 Shares of Pfizer Inc. $PFE
Aberdeen Group plc reduced its stake in Pfizer Inc. by 11.3% in the fourth quarter, selling 664,801 shares and now owning over 5.2 million shares valued at $129.6 million. Other institutional investors also adjusted their positions in Pfizer, with 68.36% of the stock held by institutional investors and hedge funds. The article also covers recent analyst ratings, Pfizer’s financial performance, and a summary of recent news impacting the company, including positive news regarding vaccine orders and RSV vaccine offerings, and negative news such as U.S. policy risks and clinical program concerns.